GLP-1 Transformation
Tirzepatide
A dual-agonist GLP-1 / GIP program designed for patients seeking advanced metabolic results under physician direction.
Available by consultation
003 — Tirzepatide protocol, placeholder.
Overview
How Tirzepatide works
The first medication in its class to engage two metabolic pathways simultaneously — and the reason its trial outcomes set a new ceiling.
- 01Engages two metabolic pathways simultaneously
- 02Highest average weight loss recorded in published GLP-1-class trials
- 03Strong, monitored response profile under physician direction
- 01Engages the GIP receptor
- Targets glucose-dependent insulinotropic polypeptide — a metabolic pathway most weight-management medications do not address.
- 02Engages the GLP-1 receptor
- Simultaneously mimics GLP-1 — suppressing appetite and slowing how quickly food leaves the stomach.
- 03Combined metabolic effect
- The dual mechanism produces the highest average weight loss recorded in any GLP-1-class clinical trial to date.
Who It’s For
A considered fit, not a funnel.
Adults seeking the most advanced GLP-1-class protocol, with the supervision and titration discipline that this medication requires.
The Right Fit
- Adults 18+ with a BMI of 27 or higher, or 25+ with weight-related conditions
- Patients who have plateaued on a single-agonist GLP-1 and want to escalate under supervision
- Members for whom faster onset and higher trial averages are clinically appropriate
Not Appropriate For
- Personal or family history of medullary thyroid carcinoma or MEN 2
- Pregnancy, breastfeeding, or planning pregnancy
- Active pancreatitis or untreated severe gastrointestinal disease
What to Expect
What to Expect
Tirzepatide tends to act faster and reach further than single-agonist GLP-1s. Your provider titrates carefully to the dose that fits your body.
01Month 1
Titration
Faster initial response than single-agonist GLP-1s. Careful dose escalation begins.
02Month 3
Established
Therapeutic dose reached. Strong metabolic momentum; appetite consistently reduced.
03Month 6
~20%
Average body weight reduction in published trials. Many members exceed this range.
04Year 1+
Sustained
Sustained reduction for the majority of members who remain in the program.
Outcomes referenced from SURMOUNT-1 trial data. Individual results depend on starting weight, dose, and adherence.
Your Care Team
A licensed clinician, matched to you.
Every Glow member is reviewed by a licensed clinician in your state from a nationwide provider network, working under the medical direction of Dr. Adrienne Guthrie. You are matched to a provider, not handed off between callcenters. Dose adjustments, check-ins, and protocol questions are routed to a real human — by direct message, on your schedule.
- 01Compounded medication
- Prepared by partner compounding pharmacies and shipped on a structured cadence.
- 02Licensed provider
- Matched from a nationwide network and accountable to your protocol — not a callcenter.
- 03Provider-directed dosing
- Titration and adjustments at every transition under physician supervision.
- 04Direct concierge messaging
- Reach your provider and care team directly between scheduled check-ins.
- 05Structured check-ins
- Cadenced reviews to keep your protocol calibrated to your response.
- 06Discreet direct delivery
- Temperature-controlled, unmarked packaging delivered direct to your door.
The Glow Standard
A standard of care built for people who expect more than telehealth.
- 01Physician-Directed
- Founded and directed by Dr. Adrienne Guthrie. Every program is informed by functional medicine, supported by a nationwide network of licensed providers, and built around the patient — not a product line.
- 02Premium Sourcing
- Compounded by partner pharmacies, prepared per protocol, delivered in discreet temperature-controlled packaging. Sourcing is a quiet promise we keep — never a marketing line.
- 03White-Glove Concierge
- A real care team, not a chatbot. Direct messaging, structured check-ins, dose adjustments at every transition, and the kind of follow-through you would expect from a private practice.
“If you stay active in your program for 6 months, follow your treatment plan, and do not achieve meaningful progress, we will work with you at no additional membership cost until you do.”
Terms apply.
Safety
No medication is right for everyone.
01
Common side effects
Most common during titration: nausea, decreased appetite, and digestive changes. Typically mild and resolve as the body adjusts to each step in the protocol.
02
Who shouldn’t take this
Not appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN 2, or for patients who are pregnant or breastfeeding. Full medical history is reviewed before any prescription is authorized.
Glow protocols are prepared by partner compounding pharmacies in the United States. Compounding pharmacies are regulated by both state boards and the FDA and have been part of American medicine since long before mass-manufactured drugs existed. The active ingredient is prepared per your protocol — supervised by your provider — and delivered direct to your door.
Members
From members of the Tirzepatide program.
“I had done six months on Semaglutide and plateaued. The switch to Tirzepatide was a second wind. I am down another twenty-two pounds in four months and feel like myself again.”
“Honestly the speed surprised me. By week three I had to start setting reminders to eat — that had never been my problem. My energy is up and my labs are better than they have been in a decade.”
“I was skeptical that the higher cost was worth it. After comparing my own progress to friends on Semaglutide, the answer for me was yes. The provider helped me think it through honestly.”
Frequently Asked
Questions worth asking before you begin.
Every Glow program begins with a consultation. If your provider authorizes treatment, your protocol is prepared by a partner compounding pharmacy and delivered direct to your door, with structured check-ins and direct messaging access to your care team throughout.
Pricing is reviewed during your consultation, where it can be presented in the context of your specific protocol and program length. Glow operates on a membership model rather than a per-item retail model.
Glow Medical Peptides operates by telehealth across all 50 states, with a nationwide network of licensed providers under the medical direction of Dr. Adrienne Guthrie.
A licensed clinician in your state, working under the medical direction of Dr. Guthrie, reviews your consultation and authorizes treatment where appropriate. You are matched to a provider rather than handed off between callcenters.
If you stay active in your program for 6 months, follow your treatment plan, and do not achieve meaningful progress, we will work with you at no additional membership cost until you do. Terms apply.
Memberships may be canceled with 30 days' notice prior to the next billing cycle. Consultations, medical visits, and fulfilled prescriptions are non-refundable once services begin or medication is processed.
Yes. Glow is HIPAA compliant. Your medical information is shared only with your assigned provider and the dispensing pharmacy. We never sell or share your data.
Considering
Semaglutide
The foundational single-agonist GLP-1 program. Lower trial averages, often the right starting point.
Begin Consultation
The Tirzepatide program begins with a conversation.
Your consultation is reviewed by a licensed clinician. If authorized, your protocol is prepared by a partner compounding pharmacy and delivered direct to your door.